Clinical Trial

CelluJuve® for the Treatment of Moderate to Severe NLFs

Name: CelluJuve® for the Treatment of Moderate to Severe NLFs — clinical trial record (NCT07545980)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Single-center, open-label proof of concept study assessing the safety and effectiveness of CelluJuve® for the treatment of moderate to severe NLFs

Protocol Amendment History 2 changes

critical Recruitment opened 2026-05-23

critical Primary endpoint(s) modified 2026-04-25

Trial Details

NCT Number	NCT07545980
Lead Sponsor	Spiderwort Biotechnologies Inc.
Conditions	Nasolabial Fold Wrinkles
Enrollment	12 participants
Start Date	2026-04-29
Primary Completion	2026-10-15 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-22